Rigel Pharmaceuticals has announced that it will initiate an offering of four million shares of common stock pursuant to an automatically effective shelf registration statement on file with the Securities and Exchange Commission.
Subscribe to our email newsletter
It is currently anticipated that the underwriters will be granted an over-allotment option for an additional 600,000 shares. Credit Suisse Securities (USA) will be acting as the sole book-runner for the offering, with Thomas Weisel Partners, Jefferies & Company, and Oppenheimer & Co. acting as co-managers.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.